Two Sigma Investments’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-27,042
| Closed | -$307K | – | 3511 |
|
|
2023
Q4 | $307K | Buy |
+27,042
| New | +$213K | ﹤0.01% | 2687 |
|
|
2023
Q3 | – | Sell |
-4,314
| Closed | -$30.6K | – | 3364 |
|
|
2023
Q2 | $30.6K | Sell |
4,314
-1,394
| -24% | -$9.64K | ﹤0.01% | 2876 |
|
|
2023
Q1 | $42.5K | Buy |
+5,708
| New | +$48K | ﹤0.01% | 2778 |
|
|
2022
Q4 | – | Sell |
-3,336
| Closed | -$32K | – | 3172 |
|
|
2022
Q3 | $32K | Buy |
3,336
+1,415
| +74% | +$26.4K | ﹤0.01% | 2352 |
|
|
2022
Q2 | $37K | Buy |
+1,921
| New | +$49.8K | ﹤0.01% | 2365 |
|
|
2022
Q1 | – | Sell |
-11,744
| Closed | -$887K | – | 4688 |
|
|
2021
Q4 | $887K | Sell |
11,744
-28,903
| -71% | -$1.97M | ﹤0.01% | 2669 |
|
|
2021
Q3 | $3.21M | Buy |
+40,647
| New | +$4.09M | 0.01% | 1561 |
|
|
2020
Q4 | – | Sell |
-2,880
| Closed | -$489K | – | 3883 |
|
|
2020
Q3 | $489K | Sell |
2,880
-22
| -0.8% | -$3.17K | ﹤0.01% | 2267 |
|
|
2020
Q2 | $482K | Sell |
2,902
-1,121
| -28% | -$175K | ﹤0.01% | 2021 |
|
|
2020
Q1 | $466K | Buy |
4,023
+68
| +2% | +$9.56K | ﹤0.01% | 1987 |
|
|
2019
Q4 | $585K | Buy |
+3,955
| New | +$600K | ﹤0.01% | 2664 |
|
Two Sigma Investments's HARP Position: Q1 2024 in Review
Two Sigma Investments sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 27,042 shares — an estimated $307K sold.
Two Sigma Investments first reported a position in HARP in Q4 2019 and held it in 11 quarters. The position peaked at $3.21M in Q3 2021. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.
- Two Sigma Investments reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Two Sigma Investments sold 27,042 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $307K.
- Two Sigma Investments first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
- Two Sigma Investments's Harpoon Therapeutics, Inc. Common Stock position peaked at $3.21M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.